Results 231 to 240 of about 259,308 (356)

Frailty and Health Outcomes in People 65 Years or Older Living With Dementia: A Systematic Review of the Literature. [PDF]

open access: yesJ Am Geriatr Soc
Borda MG   +11 more
europepmc   +1 more source

Transformation Teams Leading the Hispanic‐Serving Institutions Movement at HSI Community Colleges

open access: yesNew Directions for Community Colleges, EarlyView.
ABSTRACT The Department of Education defunded discretionary grant programs for enrollment‐based minority‐serving institutions (MSIs) on September 10, 2025, yet Hispanic‐serving institutions (HSIs) still exist and must continue to adapt to their growing population of Latine/x students.
Gina Ann Garcia   +2 more
wiley   +1 more source

The Integrated Knowledge, Dissemination, and Action Framework: A Model for Community-Engaged Translation, Dissemination, and Action. [PDF]

open access: yesHealth Promot Pract
Uphold H   +17 more
europepmc   +1 more source

Frailty and Cardiovascular Events as Determined by Body Composition: A Systematic Review

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Frailty phenotypes and risk of cardiovascular disease. Sarcopenic obese phenotype is associated with increased prevalence of cardiovascular risk factors and progression of metabolic syndrome, leading to cardiovascular events and cardiovascular mortality, while the Anorexic malnourished phenotype is associated with reduced prevalence of cardiovascular ...
Ishleen Oberoi   +5 more
wiley   +1 more source

INSTITUTIONALIZATION OF ADDITIONAL PROFESSIONAL EDUCATION AT THE HIGHER SCHOOL

open access: gold, 2014
Гузель Ильмировна Алмаева
openalex   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy